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Technology may be a cost-effective method to assess functional outcomes in survivors of 
critical illness. The primary objective of this review was to determine the extent to which 
wearable device technology, such as smartphones, pedometry, accelerometry and global 




Studies were included if they were performed in patients surviving ICU admission and 
measured outcomes using wearable devices.  
 
Data Sources and Review Method 
A scoping review searching CINALH, EMBASE, MEDLINE and PUBMED was performed. 
 
Results 
The seven studies identified were published since 2012, and were predominately descriptive 
(n=6) with one randomised controlled trial. All studies described outcomes in cohorts of 
relatively few participants [range: 11–51]. Duration to follow-up was mostly short, at a 
median time of three months post-ICU discharge [range: in-hospital to 27 years]. All studies 
used accelerometers to monitor patient movement; specifically physical activity (n=5), sleep 
quality (n=1), and infant movement (n=1). The accelerometers were bi-axial (n=3), uni-axial 
(n=2), combined uni-axial (n=1) and tri-axial (n=1). Common outcomes evaluated were the 
number of participants walking for < 30 min/day, mean daily step-counts and walking speed.  
 
Conclusions 
While wearable devices have been infrequently used to measure physical activity in survivors 
of critical illness, all identified studies were published recently, suggesting the use of wearable 
devices may be increasing. Thus far, only accelerometry has been reported, and the wide 
variation in methodologies used and the outcomes measured limits synthesis of these data.   
 
 
Highlights: (3-5 bullet points of core findings, max 85 characters) 
• Accelerometers have been used to quantify physical activity following critical illness.  














Physical activity and function is frequently impaired in survivors of critical illness [1-11]. While 
functional capacity after critical illness is an important outcome, to date, both researchers 
and clinicians have relied upon labour-intensive techniques, such as the six-minute walk test 
and subjective patient-reported questionnaires, to quantify quality of life (QOL) and physical 
function [1-10]. Given the logistical challenges and expense associated with these methods 
there is a need to be able to accurately, yet efficiently, assess physical recovery in survivors 
of critical illness in a way that is meaningful to patients and clinicians.  
 
Technological advances provide the potential to quantify physical activity in a real-life setting, 
and in a cost-effective manner. It is possible that quantifying mobility, using daily step-counts, 
or measuring how much time individuals spend at home, may provide a holistic and patient-
centric assessment of physical function. 
 
A number of relatively inexpensive and seemingly accurate pedometers and accelerometers 
are now available [12]. A pedometer measures the number of steps taken by an individual 
and an accelerometer responds to acceleration in either one, two or three planes (uni-, bi-, 
and tri-axial accelerometers, respectively). With the use of differing body mounting and 
algorithms, accelerometers can be used to assess sleep, the intensity and duration of activity, 
body position, steps and energy expenditure. They record data continuously, providing a 
more representative measure of activity. Furthermore, ambulatory global positioning system 
(GPS) devices record movement through location data. A smartphone contains a tri-axial 
accelerometer, a gyroscope, a compass, and a barometer, combining these sensors with 
appropriate software applications (apps) and algorithms has the capacity to wirelessly 
transmit live data to researchers and clinicians. Such methodology is increasingly described 
in epidemiological studies, for example McConnell and colleagues recently report using a 
smartphone app to quantify physical activity from more than 20,000 healthy individuals [13]. 
 
Given the recent advances in technology of wearable devices that record physical activity, 
there has been growth in the number of researchers evaluating these devices across different 
healthcare settings. Accelerometers and pedometers have been used to assess physical 
activity in a variety of conditions including chronic obstructive pulmonary disease [14], cystic 
fibrosis [15], multiple sclerosis [16], diabetes [17] and joint replacement preoperative 
assessment [18]. To date, however, no review has summarised the current literature on 
wearable devices in survivors of critical illness. 
   
We conducted a scoping review with the primary objective to evaluate whether wearable 
devices have been used to measure outcomes in survivors of critical illness. For the purpose 
of this review wearable devices included smartphones, pedometry, accelerometry and GPS. 
Our secondary objectives were to compare outcomes evaluated using wearable devices to 
more conventional methodologies and to evaluate usability in study participants. 
 
 
Scoping Review Question 
 
Have smartphones, pedometry, accelerometry or GPS been used to assess outcomes in 
patients who have survived an ICU admission? 
Methods 
 
Data sources and searches 
On 9 May 2016 we conducted a scoping review of the literature using four online databases 
(CINALH, EMBASE, MEDLINE and PUBMED). The search criteria are provided in 
Supplementary Table 1 (online at cicm.org.au/journal.php). All MeSH terms were expanded 
for further terms and included in the search of all four databases. Reference lists of all 




We included studies that reported outcomes in survivors of critical illness using wearable 
devices. We defined wearable devices as smartphones, pedometers, accelerometers, and GPS 
devices, based on our understanding of current technologies that could be used to assess 
outcomes following critical illness, which we defined as any condition necessitating ICU 
admission regardless of the presenting problem. No date restrictions were applied. We 
excluded studies that did not specify whether they were conducted in ICU survivors, did not 
report on the use of an aforementioned devices, and were not published in English.  
 
Study selection 
Duplicate citations were removed and titles and abstracts were independently screened for 
inclusion by two reviewers (SG and LC). If it was not clear from the abstract if the citation 
could be excluded, then the full-text article was obtained. Full-text manuscripts were 
independently evaluated for eligibility. Disagreements were resolved by consensus or 
consultation with a third reviewer (AD).  
 
Data extraction 
Two reviewers (SG and LC) independently extracted data from included studies using a 
modified version of a standardised data collection form [19]. Information extracted included 
study characteristics (author, publication year, country, design, sample size), type/s of 
technology used, outcomes from the technology used, conventional outcomes compared to 
wearable devices, and study results. 
 
Quality assessment 
Risk of bias for observational studies was assessed using the Newcastle-Ottawa Scale. The 
Newcastle-Ottawa scores studies on three domains relating to the: selection of study groups; 
comparability of groups; and ascertainment of either the exposure or outcome of interest for 
case-control or cohort studies, respectively [20]. 
 
Usability of wearable devices 
We defined usability as whether the wearable device provided a data point. We measured 
usability as the number of incomplete records, due to either user or device failure, out of the 





Our search returned 1317 references, of which 526 were duplicates. Of the 791 abstracts 
reviewed, 747 did not meet the defined inclusion criteria and were excluded. Forty-four full-
text articles were obtained and assessed for eligibility. Of these, 37 were excluded due to: 
patients were not admitted to ICU (n=10); studies were conducted during ICU admission and 
not in survivors (n=10); duplicate data (n=9), outcomes not reported (n=5) and only published 




There were five prospective observational cohort studies [22, 23, 25-27], one case control 
study [21], and one randomised controlled trial [24] (Table 1). Three studies were nested 
within larger studies: two within RCTs [23, 27] and one within a longitudinal study [25]. All 
studies were published since 2012. Using the Newcastle-Ottawa Scale the quality of all the 
observational studies were low with the major limitation to these studies being their single 
cohort and/or descriptive nature. 
 
Cohort studied 
One study was conducted in neonates who survived ICU admission [24] and one was 
conducted in adults who survived an earlier ICU admission as neonates [21]. The remainder 
were in survivors of adult ICU (Table 1), and included various enrolment criteria such as severe 
sepsis, mechanical ventilation, or ICU length of stay >5 days. All studies described outcomes 
in cohorts of relatively few participants [range; n= 11–51]. Only one study [25] included a 
calculation to determine sample size. The majority of studies evaluated their outcomes within 
three months of ICU discharge, although one measured at 18 months post- ICU, and one at a 
mean of 26 years [21, 25]. Borges et al and Guyer et al were the only investigators to report 
on outcomes at more than one time point [24, 26].  
 
Usability of wearable devices 
There were 8/301 records across all studies that failed to complete activity monitoring; four 
in Denehy’s [27] study, three in McNelly’s [25] study, and one in Edbrooke’s [23] study, 
suggesting the devices were usable. 
 
Technology reported 
All studies used accelerometers to monitor activity. The bi-axial AMP331 was the most 
commonly used accelerometer, with bi-axial accelerometers being used by three groups of 
investigators [23, 25, 27], uni-axial accelerometers by two groups [22, 24], and combined uni-
axial accelerometers [21] and tri-axial accelerometers were used by one group each [26]. 
 
Outcomes measured 
Studies evaluated physical activity (n=5) [21, 23, 25-27], sleep quality (n=1) [22], and infant 
movement (n=1) [24]. Reported outcome measures are summarised in Table 1. Several 
studies reported multiple accelerometer outcomes. The physical activity outcomes measured 
varied and included simple assessments of body position [26], walking speed [23, 26], 
duration in dynamic activities [21], distance walked [23, 27], time spent walking [26], time 
spent inactive [26, 27] and steps [23, 25, 27]. Only daily step-count [25, 27], walking speed 
[23, 26] and number of participants walking <30 minutes a day [26, 27] were reported in more 
than one study. 
 
Associations with traditional outcome measures  
Two studies reported direct correlations between outcomes measured using wearable 
devices and more ‘traditional’ outcomes, such as global reported QOL measures. There was 
a modest association between the total Physical Activity Scale for the Elderly (PASE) score and 
mean daily step-count (Spearman’s rank coefficient (rho)=0.332 p=0.05) or distance walked 
(rho=0.313 p=0.05) [27]. Stronger correlations were shown between mean daily step-count 
and both the Physical Component Summary score (r2=0.25, p<0.01) and Physical Function 
score (r2=0.51 p<0.01) of the SF-36 and with the Clinical Frailty Scale (CFS) (r2=0.55 p<0.01) 
[25]. McNelly [25] and Denehy [27] both reported that patients with chronic disease who 
survived ICU had reduced step-count compared to those without chronic disease. 
Discussion 
 
Our scoping review revealed that seven studies have reported on the use of wearable devices 
to measure outcomes in survivors of critical illness. However, as all identified studies were 
published within the last five years it appears that the use of wearable devices may be an 
emerging field of research. The use of wearable devices permits a high degree of ‘usability’ 
with only a small number of failed readings/absent data points. 
 
Our review also revealed that the majority of studies in this field have been exploratory in 
nature, and conducted in small, often single, cohorts of patients, with short-term follow-up. 
Additionally, the quality of study design was modest.  Only one RCT was identified, and three 
studies were nested in other studies. This would be consistent with an emerging field of 
research where exploratory studies frequently do not have the methodological rigor of large-
scale RCTs [28]. 
 
Variety in outcomes reported 
While the studies all utilised accelerometry to quantify outcomes, a wide variety of outcomes 
were measured and reported, such as sleep actigraphy [22] and movement assessment [24]. 
The outcome most frequently reported was locomotion. Even with this outcome, there was a 
lack of consensus between investigators on how this should be quantified. While locomotion 
was recorded in four studies [23, 25-27], the only commonly reported outcomes were mean 
daily step-count, distance walked, and the number of participants that walked for <30 
minutes/day. This variation is expected during the initial phases of a methodology but over 
time it is important that consistency in core domains is established [29]. The findings of this 
review highlight the need for the development of core outcome sets for measurement of 
physical activity in ICU survivors using technology. 
 
We were surprised there was no utilisation of GPS data to create life-spaces [30], activity-
spaces [31] or to quantify percentage time spent at home [32], as such measures have been 
used in other populations e.g. after surgery for peripheral vascular disease [33], spinal 
disorders [34], and in those with mental health issues [35]. The activity space is a geographic 
information systems construct that represents the environment an individual interacts with. 
Such measurements may provide an assessment of recovery from critical illness. We were also 
surprised that smartphones, with their associated apps, had not been used in any relevant 
study. 
 
Accelerometer methodologies  
Four identified studies reported on locomotion using algorithms to access raw accelerometer 
data to determine step data. Step data are increasingly reported in other healthcare settings 
[36-39]. It has been shown that uni-axial accelerometers are adequate for detecting heal strike 
[40] to calculate physical activity from walking, but this may under-estimate when assessing 
gait in slower walkers, particularly those with a shuffling gait [41]. It does, however, produce 
data that are patient-centered and easily interpreted by clinicians. 
 
While using locomotion data may have its advantages, the accelerometer literature suggests 
that using centrally mounted tri-axial accelerometers to count activity frequency and intensity 
would provide the best estimate of total physical activity [40], and raises the suggestion of 
using advanced modeling techniques combining accelerometer outputs to produce estimates 
of activity counts and energy expenditure [42].  
 
Although less patient-focused, the use of total activity counts to estimate energy expenditure, 
taking into account intensity and frequency of all movements, rather than just energy 
expenditure, and hence physical activity, related to walking would, perhaps, provide  a better 
assessment of physical activity. Notwithstanding the limitations of each methodology, the use 
of a single research methodology is ideal. 
 
Relationships between outcomes obtained from wearable devices compared to other 
methodologies 
It appears that there are fair associations between outcomes after critical illness measured 
using wearable devices compared with more ‘traditional’ methodologies, such as self-
reported QOL questionnaires. In this review, we found stronger associations between 
subjective measures than between subjective and objective measures, the subjective 
assessment of sleep (Pittsburgh sleep quality index) had stronger correlations with the 
subjective assessments of health-related QOL (EQ-5D and SF-36), than with objective 
actigraphy measures [22], as did the subjective assessments of physical function (SF-36) with 
frailty (CFS) than with daily step-counts [25]. It is important, prior to the widespread 
implementation of step data into critical care research, to establish that measurement of 
physical activity after critical illness is both clinically important and related to functional 
outcomes of importance to patients, their care-givers, and the community. 
 
Usability as an outcome for large trials 
Although two studies [21, 22] reported that only a subset of patients used the wearable 
devices due to availability, potentially implying a cost limitation, the cost of follow-up using 
accelerometers has not been explicitly stated in any study. An AMP331 costs $1200 (and is no 
longer produced), a Sensewear accelerometer $120 and an Actiwatch 2 (4 is discontinued) 
$1500. This is likely to be prohibitively expensive for researchers conducting trials involving 
large numbers of patients and/or sites. Fortunately, however, this cost is likely to reduce over 
time. An example of the dynamic nature of the technology landscape is that two of the 
accelerometers used in the identified studies, which were conducted within the last five years, 
have already been discontinued. The rapid evolution of these technologies and dynamic 
pricing structures is evident in that ‘market leaders’ in the commercial space, such as the FitBit 
One ($130) and Flex ($89) are comparatively inexpensive, and have been shown to be accurate 
[12]. Therefore, these dynamic changes may reduce costs however, the rapid evolution in 
makes, models and function could hinder attempts to develop core outcomes and 
methodologies using these technologies. 
 
Strengths and limitations 
Our review is, to the best of our knowledge, the first to appraise the use of wearable devices 
in ICU survivors. The strengths are: our search technique was relatively comprehensive; we 
evaluated studies for bias and quality and we used a standardised data extraction tool. 
However, we only accessed English language literature and moreover, there may be other 
wearable devices we are not aware of, and were not included in our search terms. Finally, the 
considerable heterogeneity of differing populations, wearable device outcomes, and time-




Currently, wearable devices are infrequently used to report outcomes from survivors of 
critical illness. While accelerometry was the only technology reported, there was considerable 
variation as to the type of accelerometer used, the specific outcome reported, and the time 
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Supplemental Table 1: Search terms used in each database. $ corresponds to the appropriate truncation command in each 
database.
STRING 1 STRING 2 
Critical care Mobile phone$ 
Critical$ ill$ Cell$ phone$ 
Intensive care$ Smartphone$ 
ICU$ Smart phone$ 
Intensive therapy Pedomet$ 




 Global positioning system$ 
 Cell$ telephone$ 
 Life space$ 




Year Study Design Cohort studied Number of 
patients 
Wearable Device Time to follow-up Duration of 
observation 
Observations from wearable device Other outcomes Associations 
Solverson 2016 Prospective 
observational 
cohort study 
Adults, >4 day ICU LoS. 
Excluded TBI, 
neurocognitive disorders, 
acute strokes, patients 
living a distance from the 
hospital 
55 (11 sleep 
actigraphy) 
Sleep actigraphy  3 mo post-hospital 
discharge 
3 nights Sleep/Awake cycles 
-Mean total sleep time – 6.15hrs 
- Sleep efficiency 78% 
- Number of awakenings (duration) 11 
(7mins)  
- Sleep onset latency – 12 mins. 
Sleep Quality - PSQI, 
ESS. 
HRQOL; EQ-5D, SF-36. 
Depression/anxiety; 
HADS. 
No association between total sleep 
time, sleep efficiency or sleep 
disruptions and PSQI or PSQI 
component scores. Significant 
association with APACHE II score. Total 
sleep time had no association with 
HADS, ED-5D individual domains or 
MCS or PSC.  
Edbrook 2012 Prospective 
observational 
cohort study  
(nested in 
RCT) 
Adults, sourced from a 
concurrent RCT, able to 
walk >5m without 
assistance 




Point in time, in 
hospital 
assessment 
Reported distance walked, steps taken and 
walking speed. 
Direct observation Slight underestimations of walking 
distance (2.79 (walk 1) – 3.11 (walk 2) 
m over a total of 90m)  and walking 
speed (28.87 cm/s) and a slight 
overestimation of step-count (0.92, 
95% CI -3.27 – 5.11) 
Guyer 2012 Randomised 
control trial 
Neonates <32 weeks 
gestational age 
37 Actiwatch mini and 
Actiwatch AW4 
5 and 11 wks post-
term corrected 
age 
10 days at each 
time point. 
Reduced activity count per 24 hrs in the DL 
group at 5 and 11 wks. No between group 
difference for activity count/night or day. 
Age-effect noted with increased activity 
between 5 and 11 wks 
Sleep and crying 
behavior every 5 mins in 
an auditory diary (3 
days), Weight 








Adult survivors of neonatal 
resp distress,(27 with CDH, 
30 without) 









2 days Reduced duration of dynamic activities in 
the CDH group. No difference for mean 
motility and motility during walking. No 
significant differences between groups 
Lung Function - 
Spirometry  
Exercise testing – CPET 
Fatigue – FSS 
HRQOL - LIFE-H 3.0 and 
SF36 
No correlations with wearable devices 
were reported 







Adult, >48 hrs ventilation, 
>7 d ICU LoS. Excluded;- 




30 pts (27 
provided 







18 mo post-ICU 
discharge 
>5 days, including 
one weekend day. 
Daily step-count was half that of healthy 
controls. Pre-existing chronic disease was 
associated with lower step-counts  
HRQOL - SF-36,  
Frailty - CFS 
Steps/d vs SF-36 PF r2=0.51, vs SF36  
PCS r2=0.25, vs CFS r2=0.55. Variation 
in steps vs SF-36 PF r2=0.24 vs CFS – 
r2=0.32.  
Borges 2015 Prospective 
observational 
cohort study 
Adult, severe sepsis or 
septic shock, able to walk 
without assistance pre-
admission, able to 
complete 2 assessments at 
ICU D/C Excluded;- 
previous stroke, 
neurological disease, TBI, 
SAH, SCI,  fractured limbs 
or amputation, terminal 
illness 
72 at hospital 
D/C  






Prior to hospital 
discharge and 3 
mo post discharge 
2 consecutive days 
at both time 
points. 
Septic patients had a lower walking time in 
at both time points compared to healthy 
individuals. Patients were more inactive 
(sitting or lying) on the ward, than at 3-
months. Walking intensity was lower after 
hospital discharge than healthy individuals. 
40% of septic patients walked <30 
mins/day vs 15% of healthy individuals 
Muscle strength: 






Exercise capacity - 
6MWT 
No associations between 
accelerometer data and any other 
variable during hospital admission or 
at 3-mo 
Denehy 2012 Prospective 
observational 
cohort study, 
(nested in a 
RCT) 
Adult, >5 d ICU LoS, English 
speaker, live within 50km, 
Participation agreed by the 
attending intensivist. 
Excluded neurological, 





45 PASE data 
AMP 331 
Accelerometer 
2 mo post ICU 
discharge 
7 days Participants took 4,894 (SD – 3,070) 
steps/day, 80% took <7500 and only 6% 
>10,000 steps/day. Only 54% of steps were 
taken in the locomotion category. Median 
distance walked was 1.69km. 90% of their 
time was spent inactive, 3% of the time 
was spent in the locative category. 63% of 
the cohort spent <30 mins/d in the 
locomotive category. 
Lifestyle - PASE 
questionnaire 
Exercise capacity - 
6MWD Manual Muscle 
strength - Timed up and 
go test (TUG) 
Fair correlation between total PASE 
and mean steps/day rho=0.332 and 
mean distance walked rho=0.313 at 
p=0.05. Fair correlation between PASE 
occupation sub-score and daily steps 
rho=0.332. Fair correlation between 
walking <30 mins/day from PASE and 
steps (rho=0.345) and distance 
(rho=0.344). 6MWD and SF-36 PF  
 was associated with walking time and 
steps/da in a univariate analysis, in the 
multi-variant analysis this was 
confounded by the presence of chronic 
disease. 
Table 1 - Details of the peer reviewed articles included in our scoping review – AA – Age Adjusted, 6MWD – Six-Minute Walk Distance, CDH – Congenital Diaphragmatic Hernia, d – Day, D/C  - Discharge, CFS – 
Clinical Frailty scale, CL – Cycled Light, CPET – Cardo-Pulmonary Exercise Testing, DL – Dim Light, DLCO – Diffusion capacity of the  lung for carbon monoxide,EQ-5D – EurolQol-5D, ESS – Epworth Sleepiness Scale, FEV1 – 
Forced expiratory volume in 1 sec, FSS – Fatigue Severity Score, FVC – Forced Vital Capacity, HADS – Hospital Anxiety and Depression Scale, MIP – Maximal Inspiratory Pressure, MCS – Mental Composite Score of SF-
36, PADL – Physical Activities of Daily Life, PASE – Physical activity scale for the elderly questionnaire, PCS – Physical Composite Score of SF-36, PSQI – Pittsburg Sleep Quality Index, SCI – Spinal Cord Injury, SDS – 






CINALH  –      121 
EMBASE  –      596 
MEDLINE  –      278 
PUBMED –      322 
 
Total   –      1317 
526 were duplicates 
791 titles and abstracts 
were screened for 
inclusion 
747 were excluded 
44 articles read in full 37 excluded 
10 Not in ICU patients 
10 Not in ICU survivors 
9 Duplicate data 
5 Did not report outcomes 
3 Poster abstracts 7 articles included 
Figure 1 Flow diagram for selection of studies. ICU - Intensive Care 
Unit. 
